Abingdon Health (LON:ABDX) Hits New 12-Month High – Here’s What Happened

Abingdon Health Plc (LON:ABDX) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 11 and last traded at GBX 10.49, with a volume of 1225858 shares changing hands. The stock had previously closed at GBX 10.50.

Abingdon Health Price Performance

The firm’s 50-day moving average price is GBX 7.71 and its 200-day moving average price is GBX 6.93. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The stock has a market capitalization of £23.15 million, a PE ratio of -11.38 and a beta of 0.25.

Abingdon Health (LON:ABDX) last announced its earnings results on Tuesday, March 17th. The company reported GBX (0.43) earnings per share (EPS) for the quarter. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.